GlassScriptPhysician profile
Yeu M Lo
NPI 1083293641
$1,094.65
in general payments reported to CMS, 2019-2025
16 companies · $192 in 2025
The $192 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $59.74 · 2023: $605 · 2024: $238 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,034.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $268.87 | 2023-2025 | Farxiga, Airsupra, Breztri |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $165.38 | 2023 | Xifaxan |
| Lilly USA, LLC | $128.48 | 2023-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $73.37 | 2022-2024 | Trelegy Ellipta |
| Amgen INC. | $72.59 | 2023 | Prolia, Evenity |
| Takeda Pharmaceuticals U.S.A., INC. | $56.44 | 2023 | Trintellix |
| Neurocrine Biosciences, INC. | $55.23 | 2024 | Ingrezza |
| Antares Pharma, INC. | $53.18 | 2023 | Nocdurna, Xyosted, Tlando |
| Bayer Healthcare Pharmaceuticals INC. | $37.15 | 2022-2023 | |
| Halozyme INC | $35.74 | 2023 | |
| Abbvie INC. | $34.18 | 2023-2024 | |
| Regeneron Healthcare Solutions, INC. | $32.95 | 2023 | Evkeeza |
| Teva Pharmaceuticals USA, INC. | $32.05 | 2024 | Austedo Xr |
| Novo Nordisk INC | $19.31 | 2023 | Wegovy |
| Verrica Pharmaceuticals INC. | $15.58 | 2025 | Ycanth |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $14.15 | 2023 | Flucelvax Quadrivalent, Fluad Quadrivalent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yeu Lo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.